Hint mode is switched on Switch off
For swift navigation between sections

Dermavant Sciences
LEI 54930061E5P03PWBWK21

PDF download

Choose all Reset all
Download Cancel
Organization name
Dermavant Sciences Ltd
Country name
Bermuda
Country of registration
Bermuda
Industry
Miscellaneous Healthcare: Products and Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. Dermavant leverages the Roivant platform to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    54930061E5P03PWBWK21
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001753483
Registration is required to get access.